Cargando...
Treatment of relapsed and refractory Hodgkin Lymphoma
Despite the high first line cure rates in patients with Hodgkin Lymphoma (HL) still 10–20% of patients suffer from relapsed or refractory disease. High dose chemotherapy (HDCT) followed by autologous stem cell transplant (ASCT) is standard of care for suitable patients with relapsed or refractory HL...
Gardado en:
| Publicado en: | Semin Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5637390/ https://ncbi.nlm.nih.gov/pubmed/27496309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2016.05.010 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|